Safety of Augmentin During Breastfeeding
Augmentin (amoxicillin/clavulanic acid) is safe to use during breastfeeding and is recommended as an appropriate antibiotic option for lactating mothers. 1
Evidence for Safety
- Amoxicillin/clavulanic acid is specifically recommended for breastfeeding mothers in clinical practice guidelines, indicating its established safety profile 1
- The FDA drug label acknowledges that ampicillin-class antibiotics (including amoxicillin) are excreted in breast milk but does not contraindicate its use during breastfeeding 2
- While small amounts of the drug are transferred to breast milk, the amount that an infant would ingest is significantly less than therapeutic pediatric doses 3
Clinical Considerations
- In a prospective study comparing amoxicillin/clavulanic acid to amoxicillin alone in breastfeeding women, adverse effects in infants were generally minor and self-limiting 3
- The rate of adverse effects in infants may increase with higher maternal dosages, but these effects typically don't necessitate interruption of breastfeeding 3
- Potential infant side effects to monitor for include:
Recommendations for Clinical Practice
- When prescribing Augmentin to breastfeeding mothers:
Alternative Options
- If concerns exist about using amoxicillin/clavulanic acid, other antibiotics considered safe during breastfeeding include:
Important Considerations
- The benefits of treating maternal infection generally outweigh the minimal risks to the breastfed infant 6
- Temporary interruption of breastfeeding is usually not necessary and can disrupt the nursing relationship 5
- Most commonly used antibiotics, including Augmentin, are relatively safe for breastfed babies as the dose received via milk is generally small 7